Nebius Group N.V., a technology company, engages in building full-stack infrastructure to service the global AI industry in the United States, the United Kingdom, and internationally.
Screened 2026-09-08 · the tape above runs as of 00:54 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markdown label.
Nebius Group N.V. holds its Markdown at $243.88. The statistical read favours the sellers, held for 74 days.
As held on the ledger · 2026-09-08
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 74 days
Price at the screen
$243.88
Valuation
N/A trailing · -81.36 forward price to earnings
Values screen
PASS· score 93.7
Beta
1.44
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
9.45%
Below 33%
Interest-bearing debt is just 9.4% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
7.13%
Below 33%
Cash held in interest-bearing accounts and securities is 7.1% of assets, under the one-third limit.
Pass
Receivables
0.00%
Below 49%
Money owed to the company is 0.0% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads FAIR VALUE: it trades at roughly a 18% discount to our $287.50 fair value, 454.00% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. A 17.9% margin of safety to the base estimate.
Third-party analyst targets: 16 covering, consensus Buy. The average target sits +18% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
AI infrastructure race meets stretched valuations
Picture the scramble to lay down the power-hungry GPU farms that will train tomorrow's models. Nebius is one of the smaller players racing to supply that full-stack capacity across the US, Europe and beyond.
Revenue jumped 684% last year with a 93% profit margin and 14% ROE. Those are headline numbers, yet the shares trade at 492 times forward earnings and sit 26% above our fair value of $131.47. The market is already paying for perfection.
Execution risk in a crowded field is high, and any slowdown in AI spend would hit the multiple hard. Analysts still see room to $255, but the gap to our number leaves little margin for slips. Ethical screen passed.
The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to Netherlands and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
NBIS trades on Nasdaq (the company is based in Netherlands). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-09-06Markup$220.11+0.5%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.5% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 89% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 305%. Our forward projection puts the odds of a 10% gain over the next month near 51%. The street (13 analysts) rates it buy, with a mean price target of $231.
2026-08-06Markup$218.99-3.9%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 3.9% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 89% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 305%. Our forward projection puts the odds of a 10% gain over the next month near 51%. The street (13 analysts) rates it buy, with a mean price target of $231.
2026-07-18Markup$227.81+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 89% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 305%. Our forward projection puts the odds of a 10% gain over the next month near 51%. The street (13 analysts) rates it buy, with a mean price target of $231.
2026-07-03Markup$227.81+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score (94). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$227.81Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with near-perfect ethical score (94). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
